Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Newer β-Lactam/β-Lactamase inhibitor for multidrug-resistant gram-negative infections: Challenges, implications and surveillance strategy for India.
Veeraraghavan B, Pragasam AK, Bakthavatchalam YD, Anandan S, Ramasubramanian V, Swaminathan S, Gopalakrishnan R, Soman R, Abraham OC, Ohri VC, Walia K. Veeraraghavan B, et al. Indian J Med Microbiol. 2018 Jul-Sep;36(3):334-343. doi: 10.4103/ijmm.IJMM_18_326. Indian J Med Microbiol. 2018. PMID: 30429384 Free article. Review.
Antibiotic Resistance and Epigenetics: More to It than Meets the Eye.
Ghosh D, Veeraraghavan B, Elangovan R, Vivekanandan P. Ghosh D, et al. Among authors: veeraraghavan b. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e02225-19. doi: 10.1128/AAC.02225-19. Print 2020 Jan 27. Antimicrob Agents Chemother. 2020. PMID: 31740560 Free PMC article. Review.
Levonadifloxacin, a recently approved benzoquinolizine fluoroquinolone, exhibits potent in vitro activity against contemporary Staphylococcus aureus isolates and Bengal Bay clone isolates collected from a large Indian tertiary care hospital.
Bakthavatchalam YD, Shankar A, Muniyasamy R, Peter JV, Marcus Z, Triplicane Dwarakanathan H, Gunasekaran K, Iyadurai R, Veeraraghavan B. Bakthavatchalam YD, et al. Among authors: veeraraghavan b. J Antimicrob Chemother. 2020 Aug 1;75(8):2156-2159. doi: 10.1093/jac/dkaa142. J Antimicrob Chemother. 2020. PMID: 32361727
Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3.
Bhagwat SS, Hariharan P, Joshi PR, Palwe SR, Shrivastava R, Patel MV, Devanga Ragupathi NK, Bakthavatchalam YD, Ramesh MS, Soman R, Veeraraghavan B. Bhagwat SS, et al. Among authors: veeraraghavan b. J Antimicrob Chemother. 2020 Dec 1;75(12):3563-3567. doi: 10.1093/jac/dkaa353. J Antimicrob Chemother. 2020. PMID: 32772098
In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing Klebsiella pneumoniae: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations.
Palwe S, Bakthavatchalam YD, Khobragadea K, Kharat AS, Walia K, Veeraraghavan B. Palwe S, et al. Among authors: veeraraghavan b. Antibiotics (Basel). 2021 Oct 29;10(11):1318. doi: 10.3390/antibiotics10111318. Antibiotics (Basel). 2021. PMID: 34827256 Free PMC article.
290 results